Welcome to Paid Research Studies




  • Condition:   Cranial Nerve Diseases
    Intervention:   Other: Group Isolated
    Sponsor:   Diskapi Yildirim Beyazit Education and Research Hospital
    Recruiting

  • Condition:   Cranial Nerve Palsy
    Intervention:   Procedure: preoperative cerebral MRI and operative findings
    Sponsor:   Hospices Civils de Lyon
    Recruiting

  • Conditions:   Central Nervous System Neoplasm;   Cranial Nerve Disorder;   Loss of Consciousness;   Paresis
    Interventions:   Drug: Ferumoxytol;   Drug: Gadolinium;   Procedure: Magnetic Resonance Imaging
    Sponsors:   OHSU Knight Cancer Institute;   National Cancer Institute (NCI)
    Recruiting

  • Condition:   Optic Nerve Disorders
    Intervention:  
    Sponsor:   University of Colorado, Denver
    Recruiting

  • Condition:   Optic Neuropathy
    Intervention:   Device: magnetic resonance image (MRI)
    Sponsor:   University of Miami
    Recruiting

  • Condition:   Optic Disk Drusen
    Intervention:  
    Sponsor:   Third Affiliated Hospital, Sun Yat-Sen University
    Recruiting

  • Conditions:   Concussion;   Convergence Insufficiency
    Interventions:   Behavioral: Standard Community Concussion Care (SC);   Behavioral: SC plus Simple Convergence Exercises (SC+);   Behavioral: SC plus Office-based Vergence/Accommodative Therapy (SC+OBVAT)
    Sponsors:   Mitchell Scheiman;   Ohio State University;   University of Alabama at Birmingham;   Marshall B. Ketchum University;   Stanford University;   Children's Hospital Medical Center, Cincinnati;   Children's Hospital of Philadelphia;   Boston Children’s Hospital;   New Jersey Institute of Technology
    Not yet recruiting

  • Condition:   PONV
    Interventions:   Drug: Penehyclidine;   Drug: normal saline
    Sponsor:   The First Affiliated Hospital with Nanjing Medical University
    Recruiting

  • Condition:   Acquired Esotropia
    Interventions:   Drug: Botulinum toxin type A;   Procedure: Strabismus surgery
    Sponsor:   University Hospital Inselspital, Berne
    Recruiting

  • Condition:   Strabismus
    Intervention:   Other: EyeTurn App
    Sponsors:   Massachusetts Eye and Ear Infirmary;   National Eye Institute (NEI)
    Recruiting

  • Condition:   Convergence Insufficiency Intermittent Exotropia (CI-IXT)
    Interventions:   Procedure: S-BLR;   Procedure: C-BLR
    Sponsors:   Chen Zhao;   Children's Hospital of Fudan University;   Shandong Provincial Hospital;   Shanxi Eye Hospital;   Xinhua Hospital, Shanghai Jiao Tong University School of Medicine;   Tianjin Eye Hospital;   Renmin Hospital of Wuhan University;   Second Affiliated Hospital, School of Medicine, Zhejiang University
    Not yet recruiting

  • Condition:   Exotropia Intermittent
    Interventions:   Device: Prism Glasses;   Device: Non-Prism Glasses
    Sponsors:   Jaeb Center for Health Research;   Pediatric Eye Disease Investigator Group;   National Eye Institute (NEI)
    Recruiting

  • Condition:   Exotropia
    Interventions:   Procedure: Plication strabismus surgery;   Procedure: Resection strabismus surgery
    Sponsor:   Shahid Beheshti University of Medical Sciences
    Not yet recruiting

  • Condition:   Intermittent Exotropia
    Intervention:   Other: patch therapy
    Sponsor:   Tehran University of Medical Sciences
    Not yet recruiting

  • Condition:   Intermittent Exotropia
    Intervention:   Device: Controlled Intermittent Alternate Occlusion (CIAO ) glasses
    Sponsor:   Salus University
    Recruiting

  • Condition:   Moderate Intermittent Exotropia
    Intervention:   Procedure: recession or resection of the horizontal extraocular muscles
    Sponsor:   Sun Yat-sen University
    Recruiting

  • Conditions:   Encephalitis;   Myelitis;   Guillain-Barre Syndrome;   Cranial Nerve Palsies;   Meningitis;   Zika Virus Infection;   Dengue (Virus); Fever, Sandfly;   Chikungunya Fever
    Intervention:  
    Sponsors:   Johns Hopkins University;   Universidad del Valle, Colombia;   ZikaPLAN
    Recruiting

  • Conditions:   Congenital Fibrosis of Extraocular Muscles;   Duane Retraction Syndrome;   Duane Radial Ray Syndrome;   Mobius Syndrome;   Brown Syndrome;   Marcus Gunn Syndrome;   Strabismus Congenital;   Horizontal Gaze Palsy;   Horizontal Gaze Palsy With Progressive Scoliosis;   Facial Palsy;   Facial Paresis, Hereditary, Congenital;   Third Nerve Palsy;   Fourth Nerve Palsy;   Sixth Nerve Palsy;   Synkinesis;   Ocular Motility Disorders;   Levator-Medial Rectus Synkinesis;   Athabaskan Brainstem Dysgenesis;   Tongue Paralysis;   Ninth Nerve Disorder;   Fifth Nerve Palsy;   Seventh Nerve Palsy;   Eleventh Nerve Disorder;   Twelfth Nerve Disorder;   Vagus Nerve Paralysis;   Moebius Sequence
    Intervention:  
    Sponsors:   Boston Children’s Hospital;   Howard Hughes Medical Institute;   National Eye Institute (NEI)
    Recruiting

  • Condition:   Non-Arteritic Anterior Ischemic Optic Neuropathy (NAION)
    Interventions:   Drug: Oral prednisolone administration 50 mg;   Drug: Intravenous Erythropoietin injection
    Sponsor:   Shahid Beheshti University of Medical Sciences
    Recruiting

  • Condition:   Ischemic Optic Neuropathy
    Interventions:   Drug: Alprostadil 20 micrograms;   Drug: Placebo
    Sponsor:   Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia
    Recruiting

  • Condition:   Nonarteritic Anterior Ischemic Optic Neuropathy
    Interventions:   Drug: RPh201;   Other: Placebo
    Sponsor:   Regenera Pharma Ltd
    Recruiting

  • Condition:   Anterior Ischemic Optic Neuropathy
    Interventions:   Device: Dynamic Vessel Analyzer (DVA);   Device: Fourier Domain Doppler Optical Coherence Tomography (FDOCT);   Device: Optical coherence tomography (OCT)
    Sponsor:   Medical University of Vienna
    Recruiting

  • Condition:   Acute Autoimmune Inflammatory Optic Neuritis
    Interventions:   Device: active-rtACS treatment;   Device: sham-rtACS treatment
    Sponsors:   University of Zurich;   University Hospital, Zürich;   Swiss MS Society;   Data Management, Clinical Trials Center, Zurich, Switzerland
    Not yet recruiting

  • Condition:   Optic Neuritis
    Interventions:   Device: Corticosteroid & Plasma exchange;   Drug: Corticosteroid
    Sponsor:   Chinese PLA General Hospital
    Recruiting

  • Condition:   Optic Neuritis
    Intervention:   Device: MRI
    Sponsor:   Rennes University Hospital
    Recruiting

  • Condition:   Optic Neuritis
    Interventions:   Drug: Vitamin D3;   Drug: Placebo/Standard of Care Vitamin D3
    Sponsor:   University of Calgary
    Recruiting

  • Condition:   Optic Papilla Edema
    Intervention:   Diagnostic Test: Ultrasonic Measurement will be taken from optic nerve sheat diameter and compared-classified.
    Sponsor:   Cukurova University
    Recruiting

  • Condition:   Optic Neuritis
    Interventions:   Drug: Clemastine;   Drug: Placebo
    Sponsors:   University of California, San Francisco;   Moorfields Eye Hospital NHS Foundation Trust
    Recruiting

  • Conditions:   Neuromyelitis Optica Spectrum Disorders;   Neuromyelitis Optica Spectrum Related Disorders
    Intervention:  
    Sponsor:   Hospices Civils de Lyon
    Recruiting

  • Conditions:   Parkinson's Disease;   Parkinsonian Disorders;   Atypical Parkinson Disease;   Progressive Supranuclear Palsy;   Multiple System Atrophy;   Corticobasal Degeneration;   Gait, Frontal
    Interventions:   Drug: Anti-Parkinson medication;   Device: Deep Brain Stimulation
    Sponsor:   Beth Israel Deaconess Medical Center
    Recruiting

  • Conditions:   Vestibular Schwannoma;   Meniere Disease
    Intervention:   Device: Cochlear Implant
    Sponsors:   Ohio State University;   Advanced Bionics
    Recruiting

  • Condition:   Lyme Disease
    Intervention:   Other: telephonic interview
    Sponsor:   Centre Hospitalier Universitaire de Besancon
    Recruiting

  • Condition:   Leber Hereditary Optic Neuropathy
    Intervention:   Other: Patient-reported outcomes (PROs)
    Sponsor:   GenSight Biologics
    Recruiting

  • Condition:   Leber's Hereditary Optic Neuropathy (LHON)
    Intervention:   Drug: Idebenone
    Sponsor:   Santhera Pharmaceuticals
    Recruiting

  • Condition:   Trigeminal Neuropathy, Traumatic
    Interventions:   Drug: BOTOX®, Allergan;   Drug: Placebo
    Sponsors:   Assistance Publique - Hôpitaux de Paris;   Karolinska Institutet;   University of Aarhus
    Recruiting

  • Condition:   Neuromyelitis Optica Spectrum Disorder
    Interventions:   Diagnostic Test: serum aquaporin 4 antibody (AQP-4-Ab);   Diagnostic Test: serum MOG antibody (anti-MOG);   Diagnostic Test: MRI brain, spine and orbit
    Sponsor:   Assiut University
    Recruiting

  • Condition:   Neuromyelitis Optica Spectrum Disorder
    Intervention:   Device: blood purification equipment
    Sponsors:   Third Affiliated Hospital, Sun Yat-Sen University;   Zhongshan Ophthalmic Center, Sun Yat-sen University;   Guangdong 999 Brain Hospital
    Not yet recruiting

  • Conditions:   Neuromyelitis Optica;   Devic's Disease;   NMO Spectrum Disorder
    Interventions:   Drug: Rituximab;   Drug: Cyclophosphamide;   Drug: Mesna;   Drug: rATG;   Drug: Methylprednisolone;   Drug: G-CSF;   Biological: IVIg;   Biological: Autologous Stem Cells
    Sponsor:   Northwestern University
    Recruiting

  • Condition:   Leber Hereditary Optic Neuropathy (Optic, Atrophy, Hereditary, Leber)
    Interventions:   Genetic: GS010;   Other: Sham Intravitreal Injection
    Sponsor:   GenSight Biologics
    Recruiting

  • Conditions:   Spinal Cord Disease;   Intracranial Central Nervous System Disorder;   Neurologic Disorders;   Brain Neoplasms
    Intervention:  
    Sponsor:   National Institute of Neurological Disorders and Stroke (NINDS)
    Recruiting

  • Condition:   Traumatic Optic Neuropathy
    Intervention:   Drug: Recombinant human erythropoietin
    Sponsors:   Iran University of Medical Sciences;   Mashhad University of Medical Sciences;   Shiraz University of Medical Sciences;   Tabriz University of Medical Sciences;   Tehran University of Medical Sciences
    Recruiting

  • Conditions:   Facial Palsy;   Facial Nerve Diseases;   Borrelia Infection of Central Nervous System;   Bell Palsy
    Interventions:   Drug: Prednisolone;   Drug: Placebo Oral Tablet
    Sponsors:   Dalarna County Council, Sweden;   Karolinska Institutet
    Recruiting

  • Condition:   Neuromyelitis Optica Spectrum Disorders
    Interventions:   Biological: Placebo;   Biological: RC18 160 mg
    Sponsor:   RemeGen
    Recruiting

  • Condition:   Leber's Hereditary Optic Neuropathy
    Interventions:   Drug: injection of scAAV2-P1ND4v2 1.18x10e9 vg (Low),;   Drug: injection of scAAV2-P1ND4v2 5.81 X10e9 vg (Med);   Drug: injection of scAAV2-P1ND4v2 2.4 X10e10vg (High);   Drug: injection of scAAV2-P1ND4v2 1.0 X10e11vg (Higher)
    Sponsors:   John Guy;   National Eye Institute (NEI)
    Recruiting

  • Conditions:   Parkinson Disease;   Parkinsonism;   Lewy Body Disease;   Supranuclear Palsy, Progressive;   Parkinsonism Vascular;   Multiple System Atrophy;   Corticobasal Degeneration
    Intervention:   Behavioral: Palliative Care
    Sponsors:   University of Colorado, Denver;   National Institute of Nursing Research (NINR);   University of California, San Francisco
    Recruiting

  • Conditions:   Rare Disorders;   Undiagnosed Disorders;   Disorders of Unknown Prevalence;   Cornelia De Lange Syndrome;   Prenatal Benign Hypophosphatasia;   Perinatal Lethal Hypophosphatasia;   Odontohypophosphatasia;   Adult Hypophosphatasia;   Childhood-onset Hypophosphatasia;   Infantile Hypophosphatasia;   Hypophosphatasia;   Kabuki Syndrome;   Bohring-Opitz Syndrome;   Narcolepsy Without Cataplexy;   Narcolepsy-cataplexy;   Hypersomnolence Disorder;   Idiopathic Hypersomnia Without Long Sleep Time;   Idiopathic Hypersomnia With Long Sleep Time;   Idiopathic Hypersomnia;   Kleine-Levin Syndrome;   Kawasaki Disease;   Leiomyosarcoma;   Leiomyosarcoma of the Corpus Uteri;   Leiomyosarcoma of the Cervix Uteri;   Leiomyosarcoma of Small Intestine;   Acquired Myasthenia Gravis;   Addison Disease;   Hyperacusis (Hyperacousis);   Juvenile Myasthenia Gravis;   Transient Neonatal Myasthenia Gravis;   Williams Syndrome;   Lyme Disease;   Myasthenia Gravis;   Marinesco Sjogren Syndrome(Marinesco-Sjogren Syndrome);   Isolated Klippel-Feil Syndrome;   Frasier Syndrome;   Denys-Drash Syndrome;   Beckwith-Wiedemann Syndrome;   Emanuel Syndrome;   Isolated Aniridia;   Beckwith-Wiedemann Syndrome Due to Paternal Uniparental Disomy of Chromosome 11;   Beckwith-Wiedemann Syndrome Due to Imprinting Defect of 11p15;   Beckwith-Wiedemann Syndrome Due to 11p15 Translocation/Inversion;   Beckwith-Wiedemann Syndrome Due to 11p15 Microduplication;   Beckwith-Wiedemann Syndrome Due to 11p15 Microdeletion;   Axenfeld-Rieger Syndrome;   Aniridia-intellectual Disability Syndrome;   Aniridia - Renal Agenesis - Psychomotor Retardation;   Aniridia - Ptosis - Intellectual Disability - Familial Obesity;   Aniridia - Cerebellar Ataxia - Intellectual Disability;   Aniridia - Absent Patella;   Aniridia;   Peters Anomaly - Cataract;   Peters Anomaly;   Potocki-Shaffer Syndrome;   Silver-Russell Syndrome Due to Maternal Uniparental Disomy of Chromosome 11;   Silver-Russell Syndrome Due to Imprinting Defect of 11p15;   Silver-Russell Syndrome Due to 11p15 Microduplication;   Syndromic Aniridia;   WAGR Syndrome;   Wolf-Hirschhorn Syndrome;   4p16.3 Microduplication Syndrome;   4p Deletion Syndrome, Non-Wolf-Hirschhorn Syndrome;   Autosomal Recessive Stickler Syndrome;   Stickler Syndrome Type 2;   Stickler Syndrome Type 1;   Stickler Syndrome;   Mucolipidosis Type 4;   X-linked Spinocerebellar Ataxia Type 4;   X-linked Spinocerebellar Ataxia Type 3;   X-linked Intellectual Disability - Ataxia - Apraxia;   X-linked Progressive Cerebellar Ataxia;   X-linked Non Progressive Cerebellar Ataxia;   X-linked Cerebellar Ataxia;   Vitamin B12 Deficiency Ataxia;   Toxic Exposure Ataxia;   Unclassified Autosomal Dominant Spinocerebellar Ataxia;   Thyroid Antibody Ataxia;   Sporadic Adult-onset Ataxia of Unknown Etiology;   Spinocerebellar Ataxia With Oculomotor Anomaly;   Spinocerebellar Ataxia With Epilepsy;   Spinocerebellar Ataxia With Axonal Neuropathy Type 2;   Spinocerebellar Ataxia Type 8;   Spinocerebellar Ataxia Type 7;   Spinocerebellar Ataxia Type 6;   Spinocerebellar Ataxia Type 5;   Spinocerebellar Ataxia Type 4;   Spinocerebellar Ataxia Type 37;   Spinocerebellar Ataxia Type 36;   Spinocerebellar Ataxia Type 35;   Spinocerebellar Ataxia Type 34;   Spinocerebellar Ataxia Type 32;   Spinocerebellar Ataxia Type 31;   Spinocerebellar Ataxia Type 30;   Spinocerebellar Ataxia Type 3;   Spinocerebellar Ataxia Type 29;   Spinocerebellar Ataxia Type 28;   Spinocerebellar Ataxia Type 27;   Spinocerebellar Ataxia Type 26;   Spinocerebellar Ataxia Type 25;   Spinocerebellar Ataxia Type 23;   Spinocerebellar Ataxia Type 22;   Spinocerebellar Ataxia Type 21;   Spinocerebellar Ataxia Type 20;   Spinocerebellar Ataxia Type 2;   Spinocerebellar Ataxia Type 19/22;   Spinocerebellar Ataxia Type 18;   Spinocerebellar Ataxia Type 17;   Spinocerebellar Ataxia Type 16;   Spinocerebellar Ataxia Type 15/16;   Spinocerebellar Ataxia Type 14;   Spinocerebellar Ataxia Type 13;   Spinocerebellar Ataxia Type 12;   Spinocerebellar Ataxia Type 11;   Spinocerebellar Ataxia Type 10;   Spinocerebellar Ataxia Type 1 With Axonal Neuropathy;   Spinocerebellar Ataxia Type 1;   Spinocerebellar Ataxia - Unknown;   Spinocerebellar Ataxia - Dysmorphism;   Non Progressive Epilepsy and/or Ataxia With Myoclonus as a Major Feature;   Spectrin-associated Autosomal Recessive Cerebellar Ataxia;   Spasticity-ataxia-gait Anomalies Syndrome;   Spastic Ataxia With Congenital Miosis;   Spastic Ataxia - Corneal Dystrophy;   Spastic Ataxia;   Rare Hereditary Ataxia;   Rare Ataxia;   Recessive Mitochondrial Ataxia Syndrome;   Progressive Epilepsy and/or Ataxia With Myoclonus as a Major Feature;   Posterior Column Ataxia - Retinitis Pigmentosa;   Post-Stroke Ataxia;   Post-Head Injury Ataxia;   Post Vaccination Ataxia;   Polyneuropathy - Hearing Loss - Ataxia - Retinitis Pigmentosa - Cataract;   Muscular Atrophy - Ataxia - Retinitis Pigmentosa - Diabetes Mellitus;   Non-progressive Cerebellar Ataxia With Intellectual Disability;   Non-hereditary Degenerative Ataxia;   Paroxysmal Dystonic Choreathetosis With Episodic Ataxia and Spasticity;   Olivopontocerebellar Atrophy - Deafness;   NARP Syndrome;   Myoclonus - Cerebellar Ataxia - Deafness;   Multiple System Atrophy, Parkinsonian Type;   Multiple System Atrophy, Cerebellar Type;   Multiple System Atrophy;   Maternally-inherited Leigh Syndrome;   Machado-Joseph Disease Type 3;   Machado-Joseph Disease Type 2;   Machado-Joseph Disease Type 1;   Lethal Ataxia With Deafness and Optic Atrophy;   Leigh Syndrome;   Leukoencephalopathy With Mild Cerebellar Ataxia and White Matter Edema;   Leukoencephalopathy - Ataxia - Hypodontia - Hypomyelination;   Leigh Syndrome With Nephrotic Syndrome;   Leigh Syndrome With Leukodystrophy;   Leigh Syndrome With Cardiomyopathy;   Late-onset Ataxia With Dementia;   Intellectual Disability-hyperkinetic Movement-truncal Ataxia Syndrome;   Infection or Post Infection Ataxia;   Infantile-onset Autosomal Recessive Nonprogressive Cerebellar Ataxia;   Infantile Onset Spinocerebellar Ataxia;   GAD Ataxia;   Hereditary Episodic Ataxia;   Gliadin/Gluten Ataxia;   Friedreich Ataxia;   Fragile X-associated Tremor/Ataxia Syndrome;   Familial Paroxysmal Ataxia;   Exposure to Medications Ataxia;   Episodic Ataxia With Slurred Speech;   Episodic Ataxia Unknown Type;   Episodic Ataxia Type 7;   Episodic Ataxia Type 6;   Episodic Ataxia Type 5;   Episodic Ataxia Type 4;   Episodic Ataxia Type 3;   Episodic Ataxia Type 1;   Epilepsy and/or Ataxia With Myoclonus as Major Feature;   Early-onset Spastic Ataxia-neuropathy Syndrome;   Early-onset Progressive Neurodegeneration - Blindness - Ataxia - Spasticity;   Early-onset Cerebellar Ataxia With Retained Tendon Reflexes;   Early-onset Ataxia With Dementia;   Childhood-onset Autosomal Recessive Slowly Progressive Spinocerebellar Ataxia;   Dilated Cardiomyopathy With Ataxia;   Cataract - Ataxia - Deafness;   Cerebellar Ataxia, Cayman Type;   Cerebellar Ataxia With Peripheral Neuropathy;   Cerebellar Ataxia - Hypogonadism;   Cerebellar Ataxia - Ectodermal Dysplasia;   Cerebellar Ataxia - Areflexia - Pes Cavus - Optic Atrophy - Sensorineural Hearing Loss;   Brain Tumor Ataxia;   Brachydactyly - Nystagmus - Cerebellar Ataxia;   Benign Paroxysmal Tonic Upgaze of Childhood With Ataxia;   Autosomal Recessive Syndromic Cerebellar Ataxia;   Autosomal Recessive Spastic Ataxia With Leukoencephalopathy;   Autosomal Recessive Spastic Ataxia of Charlevoix-Saguenay;   Autosomal Recessive Spastic Ataxia - Optic Atrophy - Dysarthria;   Autosomal Recessive Spastic Ataxia;   Autosomal Recessive Metabolic Cerebellar Ataxia;   Autosomal Dominant Spinocerebellar Ataxia Due to Repeat Expansions That do Not Encode Polyglutamine;   Autosomal Recessive Ataxia, Beauce Type;   Autosomal Recessive Ataxia Due to Ubiquinone Deficiency;   Autosomal Recessive Ataxia Due to PEX10 Deficiency;   Autosomal Recessive Degenerative and Progressive Cerebellar Ataxia;   Autosomal Recessive Congenital Cerebellar Ataxia Due to MGLUR1 Deficiency;   Autosomal Recessive Congenital Cerebellar Ataxia Due to GRID2 Deficiency;   Autosomal Recessive Congenital Cerebellar Ataxia;   Autosomal Recessive Cerebellar Ataxia-pyramidal Signs-nystagmus-oculomotor Apraxia Syndrome;   Autosomal Recessive Cerebellar Ataxia-epilepsy-intellectual Disability Syndrome Due to WWOX Deficiency;   Autosomal Recessive Cerebellar Ataxia-epilepsy-intellectual Disability Syndrome Due to TUD Deficiency;   Autosomal Recessive Cerebellar Ataxia-epilepsy-intellectual Disability Syndrome Due to KIAA0226 Deficiency;   Autosomal Recessive Cerebellar Ataxia-epilepsy-intellectual Disability Syndrome;   Autosomal Recessive Cerebellar Ataxia With Late-onset Spasticity;   Autosomal Recessive Cerebellar Ataxia Due to STUB1 Deficiency;   Autosomal Recessive Cerebellar Ataxia Due to a DNA Repair Defect;   Autosomal Recessive Cerebellar Ataxia - Saccadic Intrusion;   Autosomal Recessive Cerebellar Ataxia - Psychomotor Retardation;   Autosomal Recessive Cerebellar Ataxia - Blindness - Deafness;   Autosomal Recessive Cerebellar Ataxia;   Autosomal Dominant Spinocerebellar Ataxia Due to a Polyglutamine Anomaly;   Autosomal Dominant Spinocerebellar Ataxia Due to a Point Mutation;   Autosomal Dominant Spinocerebellar Ataxia Due to a Channelopathy;   Autosomal Dominant Spastic Ataxia Type 1;   Autosomal Dominant Spastic Ataxia;   Autosomal Dominant Optic Atrophy;   Ataxia-telangiectasia Variant;   Ataxia-telangiectasia;   Autosomal Dominant Cerebellar Ataxia, Deafness and Narcolepsy;   Autosomal Dominant Cerebellar Ataxia Type 4;   Autosomal Dominant Cerebellar Ataxia Type 3;   Autosomal Dominant Cerebellar Ataxia Type 2;   Autosomal Dominant Cerebellar Ataxia Type 1;   Autosomal Dominant Cerebellar Ataxia;   Ataxia-telangiectasia-like Disorder;   Ataxia-intellectual Disability-oculomotor Apraxia-cerebellar Cysts Syndrome;   Ataxia-deafness-intellectual Disability Syndrome;   Ataxia With Vitamin E Deficiency;   Ataxia With Dementia;   Ataxia Neuropathy Spectrum;   Ataxia - Tapetoretinal Degeneration;   Ataxia - Photosensitivity - Short Stature;   Ataxia - Pancytopenia;   Ataxia - Oculomotor Apraxia Type 1;   Ataxia - Hypogonadism - Choroidal Dystrophy;   Ataxia - Other;   Ataxia - Genetic Diagnosis - Unknown;   Acquired Ataxia;   Adult-onset Autosomal Recessive Cerebellar Ataxia;   Alcohol Related Ataxia;   Multiple Endocrine Neoplasia;   Multiple Endocrine Neoplasia Type II;   Multiple Endocrine Neoplasia Type 1;   Multiple Endocrine Neoplasia Type 2;   Multiple Endocrine Neoplasia, Type IV;   Multiple Endocrine Neoplasia, Type 3;   Multiple Endocrine Neoplasia (MEN) Syndrome;   Multiple Endocrine Neoplasia Type 2B;   Multiple Endocrine Neoplasia Type 2A;   Atypical Hemolytic Uremic Syndrome;   Atypical HUS;   Wiedemann-Steiner Syndrome;   Breast Implant-Associated Anaplastic Large Cell Lymphoma;   Autoimmune/Inflammatory Syndrome Induced by Adjuvants (ASIA);   Hemophagocytic Lymphohistiocytosis;   Behcet's Disease;   Alagille Syndrome;   Inclusion Body Myopathy With Early-onset Paget Disease and Frontotemporal Dementia (IBMPFD);   Lowe Syndrome;   Pitt Hopkins Syndrome;   1p36 Deletion Syndrome;   Jansen Type Metaphyseal Chondrodysplasia;   Cockayne Syndrome;   Chronic Recurrent Multifocal Osteomyelitis;   CRMO;   Malan Syndrome;   Hereditary Sensory and Autonomic Neuropathy Type Ie
    Intervention:  
    Sponsors:   Sanford Health;   National Ataxia Foundation;   International WAGR Syndrome Association;   4p- Support Group;   ML4 Foundation;   Cornelia de Lange Syndrome Foundation;   Stickler Involved People;   Kawasaki Disease Foundation;   Klippel-Feil Syndrome Alliance;   Klippel-Feil Syndrome Freedom;   Hyperacusis Research Limited;   Hypersomnia Foundation;   Kabuki Syndrome Network;   Kleine-Levin Syndrome Foundation;   Leiomyosarcoma Direct Research Foundation;   Marinesco-Sjogren Syndrome Support Group - NORD;   Mucolipidosis Type IV (ML4) Foundation;   People with Narcolepsy 4 People with Narcolepsy (PWN4PWN);   Soft Bones Incorporated;   American Multiple Endocrine Neoplasia Support;   Atypical Hemolytic Uremic Syndrome Foundation;   All Things Kabuki;   Wiedemann-Steiner Syndrome Foundation;   Breast Implant Victim Advocates;   PROS Foundation;   American Behcet's Disease Association
    Recruiting

  • Condition:   Leber Hereditary Optic Neuropathy (Optic, Atrophy, Hereditary, Leber)
    Intervention:   Genetic: GS010
    Sponsor:   GenSight Biologics
    Available

  • Conditions:   Healthy Volunteers;   Alzheimer Disease;   Progressive Supranuclear Palsy
    Intervention:   Drug: [18F]MNI-958
    Sponsor:   Invicro
    Recruiting

  • Conditions:   Progressive Supranuclear Palsy;   Dementia With Lewy Bodies;   Multiple System Atrophy;   Corticobasal Syndrome;   Atypical Parkinson Disease
    Interventions:   Behavioral: Home Visit Program;   Behavioral: Usual Care/Online Survey
    Sponsor:   Rush University Medical Center
    Recruiting

  • Conditions:   Retinal Disease;   Age-Related Macular Degeneration;   Retinitis Pigmentosa;   Stargardt Disease;   Optic Neuropathy;   Nonarteritic Ischemic Optic Neuropathy;   Optic Atrophy;   Optic Nerve Disease;   Glaucoma;   Leber Hereditary Optic Neuropathy;   Blindness;   Vision Loss Night;   Vision Loss Partial;   Vision, Low;   Retinopathy;   Maculopathy;   Macular Degeneration;   Retina Atrophy
    Interventions:   Procedure: Arm 1;   Procedure: Arm 2;   Procedure: Arm 3
    Sponsor:   MD Stem Cells
    Recruiting

  • Conditions:   Brain Disorders;   Birth Defects;   Craniofacial Differences
    Intervention:  
    Sponsors:   National Human Genome Research Institute (NHGRI);   National Eye Institute (NEI);   Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD);   Icahn School of Medicine at Mount Sinai;   Boston Children’s Hospital
    Recruiting

  • Conditions:   Neurologic Disorders;   Nervous System Diseases;   Neurodegenerative Diseases;   Neurological Disorders;   Stroke;   Traumatic Brain Injury;   Cadasil;   Chronic Traumatic Encephalopathy;   Cerebral Infarction;   Cerebral Ischemia;   Cerebral Stroke;   Cerebral Hemorrhage;   Parkinson;   Multi-System Degeneration;   MSA - Multiple System Atrophy;   Progressive Supranuclear Palsy;   ALS;   Amyotrophic Lateral Sclerosis;   Neuropathy;   Diabetic Neuropathies
    Interventions:   Procedure: Intravenous BMSC;   Procedure: Intranasal BMSC
    Sponsor:   MD Stem Cells
    Recruiting

  • Conditions:   Frontotemporal Lobar Degeneration;   Amytrophic Lateral Sclerosis;   Progressive Supranuclear Palsy
    Intervention:  
    Sponsor:   National Institute of Neurological Disorders and Stroke (NINDS)
    Recruiting

  • Conditions:   Neuromyelitis Optica;   NMO Spectrum Disorder
    Intervention:  
    Sponsors:   Mayo Clinic;   Alexion Pharmaceuticals
    Recruiting

  • Conditions:   Neuromyelitis Optica;   Neuromyelitis Optica Spectrum Disorder;   Transverse Myelitis;   Optic Neuritis
    Intervention:  
    Sponsor:   University of Texas Southwestern Medical Center
    Recruiting

  • Conditions:   Eye Diseases Hereditary;   Retinal Disease;   Achromatopsia;   Bardet-Biedl Syndrome;   Bassen-Kornzweig Syndrome;   Batten Disease;   Best Disease;   Choroidal Dystrophy;   Choroideremia;   Cone Dystrophy;   Cone-Rod Dystrophy;   Congenital Stationary Night Blindness;   Enhanced S-Cone Syndrome;   Fundus Albipunctatus;   Goldmann-Favre Syndrome;   Gyrate Atrophy;   Juvenile Macular Degeneration;   Kearns-Sayre Syndrome;   Leber Congenital Amaurosis;   Refsum Syndrome;   Retinitis Pigmentosa;   Retinitis Punctata Albescens;   Retinoschisis;   Rod-Cone Dystrophy;   Rod Dystrophy;   Rod Monochromacy;   Stargardt Disease;   Usher Syndrome
    Intervention:  
    Sponsor:   Foundation Fighting Blindness
    Recruiting

  • Condition:   Trigeminal Neuralgia
    Interventions:   Drug: Lidocaine;   Drug: Guanfacine
    Sponsor:   Vanderbilt University Medical Center
    Not yet recruiting

  • Conditions:   Alzheimer Disease;   Mild Cognitive Impairment;   Progressive Supranuclear Palsy
    Intervention:   Drug: Radiopharmaceuticals
    Sponsors:   University of California, Berkeley;   University of California, San Francisco
    Recruiting

  • Conditions:   Alzheimer Disease (AD);   Frontotemporal Lobar Degeneration;   Dementia With Lewy Bodies (DLB);   Parkinson Disease Dementia (PDD);   Progressive Supranuclear Palsy (PSP);   Corticobasal Degeneration (CBD)
    Intervention:  
    Sponsors:   Amoneta Diagnostics SAS;   European Commission;   Firalis SA;   University Hospital, Strasbourg;   Centre Hospitalier Universitaire Vaudois;   IRCCS Centro San Giovanni di Dio Fatebenefratelli;   Hôpitaux Civils de Colmar;   Istanbul University;   Assistance Publique - Hôpitaux de Paris;   University Hospital, Lille;   University Hospital, Geneva;   Cliniques universitaires Saint-Luc- Université Catholique de Louvain;   Erasme University Hospital;   University Hospital, Montpellier;   Centre Hospitalier Universitaire de Besancon;   Centre Hospitalier Universitaire de Nice
    Recruiting

  • Condition:   Non Arteritic Ischemic Optic Neuropathy
    Intervention:   Procedure: intravitreal injection of MSV
    Sponsors:   Instituto Universitario de Oftalmobiología Aplicada (Institute of Applied Ophthalmobiology) - IOBA;   University of Valladolid
    Recruiting

  • Condition:   Ophthalmoplegia
    Intervention:   Device: 3D PD T1 MRI sequence
    Sponsor:   Fondation Ophtalmologique Adolphe de Rothschild
    Recruiting

  • Condition:   Ophthalmoplegia
    Intervention:   Diagnostic Test: MRI T2 sequence of the oculomotor tract
    Sponsor:   Fondation Ophtalmologique Adolphe de Rothschild
    Recruiting

  • Conditions:   Unilateral Vocal Cord Paralysis;   Central Auditory Processing Disorder
    Intervention:  
    Sponsor:   Cliniques universitaires Saint-Luc- Université Catholique de Louvain
    Recruiting

  • Conditions:   Pituitary Tumor;   Meningioma;   Rathke Cleft Cysts;   Chordoma;   Chondrosarcoma;   Craniopharyngioma;   Encephalocele;   Esthesioneuroblastoma
    Intervention:  
    Sponsor:   Ohio State University
    Recruiting

  • Conditions:   Sclerosis, Multiple;   Neuromyelitis Optica Spectrum Disorder;   Myelin Oligodendrocyte Glycoprotein (MOG)-Antibody Related Disorders;   Pregnancy Abnormal
    Intervention:   Other: No intervention
    Sponsor:   Hospices Civils de Lyon
    Not yet recruiting

  • Conditions:   Spinal Accessory Nerve Injury;   Cervical Lymphadenopathy
    Intervention:   Device: AxoGuard Nerve Cuff
    Sponsor:   University of Mississippi Medical Center
    Recruiting

  • Conditions:   Ischemic Optic Neuropathy;   Branch Retinal Artery Occlusion;   Hemianopia;   Leber Hereditary Optic Neuropathy;   Acute Zonal Occult Outer Retinopathy
    Intervention:   Device: LSFG-NAVI
    Sponsor:   Randy Kardon
    Recruiting

  • Conditions:   Meniere's Disease;   Benign Paroxysmal Positional Vertigo;   Recurrent Vestibulopathy;   Vestibular Migraine
    Intervention:   Device: CAVA Device
    Sponsors:   Julie Dawson;   University of East Anglia
    Recruiting

  • Conditions:   Pituitary Tumor;   Surgery;   Olfactory Nerve Injuries
    Intervention:   Procedure: Electrocautery versus scalpel
    Sponsor:   St. Michael's Hospital, Toronto
    Recruiting

  • Conditions:   Acute Leukemia;   Adenomatous Polyposis;   Adrenocortical Carcinoma;   AML;   BAP1 Tumor Predisposition Syndrome;   Carney Complex;   Choroid Plexus Carcinoma;   Constitutional Mismatch Repair Deficiency Syndrome;   Diamond-Blackfan Anemia;   DICER1 Syndrome;   Dyskeratosis Congenita;   Emberger Syndrome;   Familial Acute Myeloid Leukemia;   Familial Adenomatous Polyposis;   Fanconi Anemia;   Familial Cancer;   Familial Wilms Tumor;   Familial Neuroblastoma;   GIST;   Hereditary Breast and Ovarian Cancer;   Hereditary Paraganglioma-Pheochromocytoma Syndrome;   Hodgkin Lymphoma;   Juvenile Polyposis;   Li-Fraumeni Syndrome;   Lynch Syndrome;   MDS;   Melanoma Syndrome;   Multiple Endocrine Neoplasia Type 1;   Multiple Endocrine Neoplasia Type 2;   Neuroblastoma;   Neurofibromatosis Type 1;   Neurofibromatosis Type II;   Nevoid Basal Cell Carcinoma Syndrome;   Non Hodgkin Lymphoma;   Noonan Syndrome and Other Rasopathy;   Overgrowth Syndromes;   Pancreatic Cancer;   Peutz-Jeghers Syndrome;   Pheochromocytoma/Paraganglioma;   PTEN Hamartoma Tumor Syndrome;   Retinoblastoma;   Rhabdoid Tumor Predisposition Syndrome;   Rhabdomyosarcoma;   Rothmund-Thomson Syndrome;   Tuberous Sclerosis;   Von Hippel-Lindau Disease
    Intervention:  
    Sponsor:   St. Jude Children's Research Hospital
    Recruiting

  • Conditions:   FTLD;   Progressive Supranuclear Palsy (PSP);   Frontotemporal Dementia (FTD);   Corticobasal Degeneration (CBD);   PPA Syndrome;   Behavioral Variant Frontotemporal Dementia (bvFTD);   Semantic Variant Primary Progressive Aphasia (svPPA);   Nonfluent Variant Primary Progressive Aphasia (nfvPPA);   FTD With Amyotrophic Lateral Sclerosis (FTD/ALS);   Amyotrophic Lateral Sclerosis (ALS);   Oligosymptomatic PSP (oPSP);   Corticobasal Syndrome (CBS)
    Intervention:  
    Sponsors:   University of California, San Francisco;   National Center for Advancing Translational Science (NCATS);   National Institute of Neurological Disorders and Stroke (NINDS);   The Bluefield Project;   Tau Consortium
    Recruiting

  • Conditions:   Parkinsonian Syndromes;   Parkinson's Disease;   Multiple System Atrophy;   Progressive Supranuclear Palsy
    Interventions:   Other: CSF, blood and urine sampling;   Other: clinical measures of disease severity and progression
    Sponsor:   University Hospital, Bordeaux
    Recruiting

  • Conditions:   Multiple Sclerosis;   Optic Neuritis
    Interventions:   Device: Transorbital electrical stimulation (Eyetronic Next Wave 1.1);   Device: Transorbital electrical stimulation (Eyetronic Next Wave 1.1) - Sham stimulation
    Sponsors:   Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts;   Fondation ARSEP;   APHP
    Recruiting

  • Conditions:   Mitochondrial Diseases;   Mitochondrial Myopathies;   Progressive External Ophthalmoplegia;   Progressive Ophthalmoplegia;   Progressive; Ophthalmoplegia, External;   Mitochondria DNA Deletion;   MELAS;   Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-Like Episodes;   Mitochondrial Encephalopathy, Lactic Acidosis and Stroke-Like Episodes (MELAS Syndrome)
    Intervention:   Dietary Supplement: Nicotinamide Riboside
    Sponsors:   Cambridge University Hospitals NHS Foundation Trust;   University of Cambridge;   MRC Mitochondrial Biology Unit
    Recruiting

  • Conditions:   Thyroid Cancer;   Recurrent Laryngeal Nerve Injuries
    Intervention:   Procedure: Reversed Tracking Method
    Sponsor:   Fujian Medical University
    Recruiting

  • Conditions:   Acute LHON;   Onset Within Three Months;   Onset Between 3 to 6 Months;   Onset Between 6 to 12 Months;   Onset Between 12 to 24 Months;   Onset Between 24 to 60 Months;   Onset Over 60 Months
    Intervention:   Drug: rAAV2-ND4
    Sponsor:   Bin Li
    Recruiting

  • Conditions:   Relapsing Remitting Multiple Sclerosis;   Optic Neuropathy;   Optic; Neuritis, With Demyelination
    Interventions:   Drug: CNM-Au8;   Drug: Placebo
    Sponsors:   Clene Nanomedicine;   Clene Australia Pty Ltd
    Recruiting

  • Conditions:   Macular Holes;   Epiretinal Membrane;   Diabetic Retinopathy;   Retinal Detachment;   Retinal Disease;   Preretinal Fibrosis;   Cataract;   Ocular Tumor;   Strabismus;   Healthy
    Intervention:   Device: Microscope integrated optical coherence tomography
    Sponsors:   Duke University;   National Eye Institute (NEI)
    Recruiting

  • Conditions:   Guillain-Barré Syndrome;   Miller Fisher Syndrome
    Intervention:  
    Sponsor:   Erasmus Medical Center
    Recruiting

  • Conditions:   Migraine in Children;   Sphenopalatine Neuralgia;   Migraine in Adolescence
    Interventions:   Drug: Lidocaine topical;   Drug: Prochlorperazine Injection
    Sponsor:   Newark Beth Israel Medical Center
    Recruiting

  • Conditions:   Anesthesia;   Strabismus;   PONV
    Interventions:   Drug: Palonosetron;   Drug: Dexamethasone
    Sponsor:   Universidade Federal Fluminense
    Recruiting

  • Conditions:   Humoral Rejection;   Guillain-Barre Syndrome;   Miller Fisher Syndrome;   CIDP;   Good Pasture Syndrome;   Hyperviscosity Syndrome
    Interventions:   Drug: Fibrinogen concentrate;   Other: Fresh Frozen Plasma
    Sponsor:   University Medical Centre Ljubljana
    Recruiting

  • Conditions:   Vocal Cord Paralysis Unilateral;   Dysphonia;   Dysphagia, Oropharyngeal
    Intervention:   Procedure: Silk Microparticle Filler Injection
    Sponsors:   University of Southern California;   Sofregen Medical, Inc.
    Not yet recruiting

  • Conditions:   Concussion, Mild;   Convergence Insufficiency;   Accommodation; Insufficiency
    Intervention:   Device: Glasses
    Sponsor:   University of Alabama at Birmingham
    Recruiting

  • Condition:   Cancer
    Intervention:   Biological: Antigen-specific T cells CART/CTL and DCvac
    Sponsor:   Shenzhen Geno-Immune Medical Institute
    Recruiting

  • Condition:   Vestibular Schwannoma
    Intervention:   Diagnostic Test: Probabilistic diffusion tensor tractography
    Sponsors:   King's College Hospital NHS Trust;   Guy's and St Thomas' NHS Foundation Trust
    Recruiting

  • Condition:   Acoustic Neuroma
    Intervention:   Other: Scale of quality life
    Sponsor:   University Hospital, Bordeaux
    Recruiting

  • Condition:   Neuroma, Acoustic
    Intervention:  
    Sponsor:   University Hospital, Strasbourg, France
    Recruiting

  • Conditions:   Vestibular Schwannoma;   Cochlear Implantation
    Intervention:   Device: Cochlear implant
    Sponsor:   Ascension South East Michigan
    Recruiting

  • Conditions:   Neurofibromatosis 2;   Dermatology/Skin - Other
    Intervention:   Other: no intervention
    Sponsor:   Centre Hospitalier Universitaire de Nice
    Recruiting

  • Condition:   Vestibular Vertigo
    Interventions:   Drug: Intranasal Drug;   Drug: Oral Tablet;   Other: Intranasal Placebo
    Sponsor:   Auris Medical AG
    Not yet recruiting

  • Conditions:   Subcondylar Process of Mandible Open Fracture;   Facial Nerve Injuries
    Interventions:   Procedure: PRA approach;   Procedure: RT approach
    Sponsor:   Hani Taher Hibatullah Ali
    Not yet recruiting

  • Conditions:   Vestibular Schwannoma;   Hearing Loss
    Intervention:  
    Sponsor:   Christoph Arnoldner
    Recruiting

  • Conditions:   Vestibular Schwannoma;   Hearing Loss
    Intervention:   Other: eABR
    Sponsor:   Christoph Arnoldner
    Recruiting

  • Condition:   Trigeminal Neuralgia
    Interventions:   Drug: Erenumab;   Drug: Placebos
    Sponsor:   Danish Headache Center
    Not yet recruiting

  • Conditions:   CNS Tumors;   Meningioma;   Esthesioneuroblastoma;   Hemangioblastoma;   Medulloblastoma;   Paraganglioma;   Pituitary Adenoma
    Intervention:   Diagnostic Test: Ga68-DOTATATE-PET/MRI
    Sponsor:   Weill Medical College of Cornell University
    Recruiting

  • Conditions:   Strabismus;   Reflex, Oculocardiac;   Hydroxyzine;   Bradycardia Sinus
    Interventions:   Drug: Midazolam;   Drug: Hydroxyzine Dihydrochloride
    Sponsor:   Yeditepe University
    Recruiting

  • Conditions:   Hemifacial Paralysis;   Bell Palsy
    Interventions:   Device: Electrical Stimulation;   Device: Sham Treatment
    Sponsors:   The Hospital for Sick Children;   The Physicians' Services Incorporated Foundation
    Not yet recruiting

  • Condition:   Trigeminal Neuralgia
    Interventions:   Drug: Rimegepant;   Drug: Placebo
    Sponsor:   Biohaven Pharmaceuticals, Inc.
    Recruiting

  • Conditions:   Recurrent Laryngeal Nerve Palsy;   Postoperative Dysphonia
    Intervention:   Device: Transcutaneous Laryngeal Ultrasonography
    Sponsors:   Assistance Publique - Hôpitaux de Paris;   MINDRAY
    Not yet recruiting

  • Condition:   Optic Neuritis
    Intervention:  
    Sponsor:   Fondation Ophtalmologique Adolphe de Rothschild
    Not yet recruiting

  • Conditions:   Diabetes Mellitus, Type 1;   Monogenic Diabetes;   Neonatal Diabetes;   Maturity-onset Diabetes in the Young (MODY);   Wolfram Syndrome;   Wolcott-Rallison Syndrome;   Mitochondrial Diabetes
    Intervention:  
    Sponsor:   Constantin Polychronakos
    Not yet recruiting

  • Condition:   Wolfram Syndrome
    Intervention:  
    Sponsor:   Washington University School of Medicine
    Recruiting

  • Conditions:   Multiple Sclerosis, Relapsing-Remitting;   Neuromyelitis Optica;   Acute Disseminated Encephalomyelitis;   Transverse Myelitis
    Intervention:  
    Sponsor:   University of Texas Southwestern Medical Center
    Not yet recruiting

  • Condition:   Bilateral Vocal Cord Paralysis
    Intervention:  
    Sponsor:   Weill Medical College of Cornell University
    Recruiting

  • Condition:   Treatment
    Interventions:   Drug: Suvorexant;   Drug: Zolpidem;   Drug: Placebo oral capsule
    Sponsors:   University of California, San Francisco;   US Department of Veterans Affairs
    Recruiting

  • Condition:   Progressive Supranuclear Palsy
    Interventions:   Drug: AZP2006 oral solution;   Drug: Placebo oral solution
    Sponsor:   AlzProtect SAS
    Not yet recruiting

  • Condition:   Facial Palsy
    Intervention:   Behavioral: Information and Therapy Guides
    Sponsor:   Oxford University Hospitals NHS Trust
    Recruiting

  • Conditions:   Optic Neuritis;   Neuromyelitis Optica;   Multiple Sclerosis
    Intervention:   Diagnostic Test: Neuro-ophtalmology examination
    Sponsors:   University Hospital Center of Martinique;   University Hospital Center of Guadeloupe;   Hospital Center of Cayenne (French Guyana)
    Recruiting

  • Condition:   Unilateral Vocal Cord Paralysis
    Interventions:   Procedure: Acid hyaluronic injection laryngoplasty;   Behavioral: Voice therapy;   Other: Sham of injection;   Other: Sham of voice therapy
    Sponsor:   Cliniques universitaires Saint-Luc- Université Catholique de Louvain
    Not yet recruiting

  • Conditions:   Mild Traumatic Brain Injury;   Vestibular Neuropathy
    Interventions:   Device: Incremental Velocity Error (IVE);   Behavioral: Traditional Vestibular Rehabilitation (VPT)
    Sponsors:   Johns Hopkins University;   Fort Belvoir Community Hospital;   Neuroscience Research Australia;   Walter Reed National Military Medical Center
    Not yet recruiting

  • Conditions:   Amblyopia;   Strabismus
    Intervention:   Device: Retinal Birefringence Imager
    Sponsors:   Rebiscan, Inc.;   Retina Foundation of the Southwest
    Not yet recruiting

  • Conditions:   Neurofibromatosis Type 1;   Plexiform Neurofibroma;   Optic Nerve Glioma
    Intervention:   Drug: Selumetinib
    Sponsors:   Great Ormond Street Hospital for Children NHS Foundation Trust;   AstraZeneca
    Not yet recruiting

  • Condition:   Vestibular Neuritis
    Interventions:   Other: Vestibular rehabilitation;   Drug: Corticosteroid
    Sponsor:   Aalborg University Hospital
    Recruiting

  • Condition:   Trigeminal Neuralgia (TN)
    Intervention:   Procedure: transcranial electrical brain stimulation
    Sponsors:   University of Florida;   Facial Pain Research Foundation
    Recruiting

  • Condition:   Bell Palsy
    Intervention:   Device: electrical stimulation device (tens unit)
    Sponsor:   Oregon Health and Science University
    Recruiting

  • Condition:   Vestibular Schwannoma
    Intervention:  
    Sponsor:   Haukeland University Hospital
    Recruiting

  • Condition:   Trigeminal Neuralgia
    Intervention:   Drug: Fosphenytoin
    Sponsor:   Danish Headache Center
    Recruiting

  • Conditions:   Acoustic Neuroma;   Labyrinthitis Ossificans;   Profound Hearing Impairment
    Intervention:   Device: MedEl Test Electrode Placer
    Sponsors:   Eric W. Sargent, MD;   Med-El Corporation
    Recruiting

  • Condition:   Trigeminal Neuralgia
    Intervention:   Other: telephone survey
    Sponsor:   University Hospital, Limoges
    Recruiting

  • Condition:   Wolfram Syndrome
    Interventions:   Drug: Sodium Valproate 200Mg E/C Tablet;   Drug: Sodium Valproate matched placebo
    Sponsor:   University of Birmingham
    Recruiting

  • Conditions:   Thyroidectomy;   Paralysis of Vocal Cords
    Intervention:   Diagnostic Test: Pre and postoperative ultrasound
    Sponsors:   Lille Catholic University;   University Hospital, Lille
    Recruiting

  • Condition:   Esthesioneuroblastoma, Olfactory
    Intervention:  
    Sponsor:   Ricardo L. Carrau, MD
    Recruiting

  • Condition:   Trigeminal Neuralgia
    Interventions:   Drug: BIIB074;   Drug: Placebo
    Sponsor:   Biogen
    Not yet recruiting

  • Conditions:   Corticobasal Syndrome;   Progressive Supranuclear Palsy;   Behavioral Variant Frontotemporal Dementia;   Semantic Dementia;   Progressive Nonfluent Aphasia;   Amyotrophic Lateral Sclerosis and/or Frontotemporal Dementia
    Intervention:   Other: Observational Study
    Sponsor:   University Health Network, Toronto
    Recruiting

  • Conditions:   Dysphonia;   Unilateral Vocal Cord Paralysis
    Interventions:   Other: Standard of care voice therapy;   Device: Expiratory muscle strength training (EMST)
    Sponsor:   University of Miami
    Not yet recruiting

  • Condition:   Strabismus
    Intervention:  
    Sponsor:   Second Affiliated Hospital, School of Medicine, Zhejiang University
    Recruiting

  • Condition:   Facial Paralysis
    Intervention:   Behavioral: Mindfulness Meditation Phone Application
    Sponsor:   Johns Hopkins University
    Not yet recruiting

  • Condition:   Facial Palsy
    Intervention:   Other: Records
    Sponsor:   Association pour le Développement et l'Organisation de la Recherche en Pneumologie et sur le Sommeil
    Recruiting

  • Conditions:   Emergence Delirium;   Strabismus
    Intervention:   Drug: Methadone
    Sponsor:   Ochsner Health System
    Recruiting

  • Conditions:   Bell Palsy;   Idiopathic Facial Paralyses
    Interventions:   Other: Laser acupuncture therapy;   Other: Sham laser acupuncture therapy
    Sponsor:   China Medical University Hospital
    Recruiting

  • Conditions:   Neurofibromatosis 2;   Vestibular Schwannoma;   Meningioma;   Ependymoma;   Glioma
    Intervention:   Drug: Selumetinib
    Sponsors:   Children's Hospital Medical Center, Cincinnati;   AstraZeneca
    Recruiting

  • Condition:   Recurrent Paralysis of Vocal Cords
    Interventions:   Drug: Corticoids;   Other: Placebo
    Sponsor:   Poitiers University Hospital
    Recruiting

  • Conditions:   Vestibular Schwannoma;   Acoustic Neuroma;   Neurofibromatosis 2
    Interventions:   Drug: Aspirin;   Drug: Placebo
    Sponsors:   Massachusetts Eye and Ear Infirmary;   United States Department of Defense;   Massachusetts General Hospital
    Recruiting

  • Condition:   Acoustic Neuroma
    Intervention:   Other: Testing of Pre-Positioning Frame
    Sponsors:   Vanderbilt University Medical Center;   National Institute on Deafness and Other Communication Disorders (NIDCD)
    Not yet recruiting

  • Conditions:   Hearing Loss, Cochlear;   Neurinoma of the Acoustic Nerve
    Interventions:   Device: Neuristim;   Device: Cochlear implant
    Sponsor:   Oticon Medical
    Recruiting

  • Condition:   Bell Palsy
    Interventions:   Drug: Oral Corticosteroids;   Drug: Oral antivirals;   Device: Hyperbaric Oxygen Therapy
    Sponsor:   NYU Langone Health
    Not yet recruiting

  • Conditions:   Multiple Sclerosis, Relapsing-Remitting;   Optic Neuritis
    Interventions:   Device: Dynamic Vessel Analyzer (DVA);   Device: Fourier Domain Doppler Optical Coherence Tomography (FDOCT);   Device: Optical coherence tomography (OCT);   Device: Optical coherence tomography angiography (OCTA)
    Sponsor:   Medical University of Vienna
    Recruiting

  • Condition:   Trigeminal Neuralgia
    Intervention:   Drug: Oxtellar XR 150Mg Extended Release Tablet
    Sponsor:   University of Colorado, Denver
    Not yet recruiting

  • Conditions:   Frontotemporal Degeneration;   Progressive Supranuclear Palsy;   Multiple System Atrophy
    Intervention:   Other: None-Observation Only
    Sponsor:   University of Pennsylvania
    Recruiting

  • Condition:   Trigeminal Neuralgia
    Interventions:   Drug: Botulinum Toxin type A (intradermal / submucosal injection at pain area);   Drug: Botulinum Toxin type A (intra-masseter injection on the ipsilateral of pain involved)
    Sponsor:   The First Affiliated Hospital of Zhengzhou University
    Recruiting

  • Conditions:   Cutaneous Neurofibroma;   Neurofibromatosis Type 1;   NF1 Gene Mutation;   Optic Nerve Glioma
    Interventions:   Other: Laboratory Biomarker Analysis;   Drug: Selumetinib;   Drug: Selumetinib Sulfate
    Sponsor:   National Cancer Institute (NCI)
    Recruiting

  • Condition:   Trigeminal Neuralgia
    Interventions:   Drug: BIIB074;   Drug: Placebo
    Sponsor:   Biogen
    Not yet recruiting

  • Condition:   Optic Nerve Sheath Tumors, Benign
    Intervention:   Radiation: Multisession Radiosurgery
    Sponsor:   Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta
    Recruiting

  • Conditions:   Orofacial Pain;   Trigeminal Neuralgia
    Intervention:   Other: occlusal adjustment
    Sponsor:   Meiqing Wang
    Recruiting

  • Conditions:   Wolfram Syndrome;   Diabetes Mellitus;   Optic Nerve Atrophy;   Ataxia
    Intervention:   Drug: dantrolene sodium
    Sponsors:   Washington University School of Medicine;   National Institutes of Health (NIH)
    Recruiting

  • Conditions:   Wolfram Syndrome;   Diabetes Mellitus;   Optic Nerve Atrophy;   Deafness;   Diabetes Insipidus;   Ataxia
    Intervention:  
    Sponsors:   Washington University School of Medicine;   American Diabetes Association;   National Institutes of Health (NIH)
    Recruiting

  • Condition:   Trigeminal Neuralgia
    Interventions:   Device: Unframed Virtual Cone;   Radiation: 80 Gy Radiation
    Sponsor:   University of Alabama at Birmingham
    Recruiting

  • Conditions:   Glioma;   Pilocytic Astrocytoma;   Anaplastic Astrocytoma;   Glioblastoma;   Mixed Oligoastrocytoma;   Mixed Glioma;   Oligodendroglioma;   Optic Glioma;   Astrocytoma
    Interventions:   Device: MRI-guided laser ablation;   Drug: Doxorubicin;   Drug: Etoposide;   Device: Dynamic contrast-enhanced (DCE) MRI;   Device: Dynamic susceptibility contrast (DSC) MRI
    Sponsor:   Washington University School of Medicine
    Recruiting

  • Conditions:   Dizziness;   Vertigo;   Vestibular Neuritis
    Interventions:   Behavioral: BI + VR + CBT;   Behavioral: BI + phone calls
    Sponsors:   Bergen University College;   University of Bergen;   Norwegian Fund for Postgraduate Training in Physiotherapy;   University of Southern Denmark;   Duke University;   Haukeland University Hospital
    Recruiting

  • Condition:   Progressive Supranuclear Palsy
    Intervention:   Drug: F-18 AV 1451
    Sponsor:   Mayo Clinic
    Recruiting

  • Conditions:   Sporadic Acoustic Neuromas;   Useful Hearing
    Intervention:   Radiation: Radiosurgery
    Sponsor:   Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta
    Recruiting

  • Conditions:   Opsoclonus Myoclonus Syndrome;   Neuroblastoma
    Interventions:   Drug: Dexamethasone acetate;   Drug: dexamethasone and cyclophosphamide;   Drug: dexamethasone and rituximab
    Sponsor:   Institut Curie
    Recruiting

  • Conditions:   Multiple Sclerosis;   Neuromyelitis Optica
    Intervention:   Biological: Tolerogenic Dendritic cells loaded with myelin peptides
    Sponsor:   Sara Varea
    Recruiting

  • Conditions:   Neurofibromatosis 1;   Neurofibromatosis 2;   Schwannomatosis
    Intervention:  
    Sponsor:   The Children's Tumor Foundation
    Recruiting

  • Conditions:   Pilomyxoid Astrocytoma;   Pilocytic Astrocytoma;   Glioma, Astrocytic;   Optic Nerve Glioma;   Pleomorphic Xanthoastrocytoma;   Glioblastoma Multiforme;   Anaplastic Astrocytoma;   Gliosarcoma;   Diffuse Intrinsic Pontine Glioma;   DIPG;   Low-grade Glioma;   Brainstem Glioma
    Interventions:   Drug: Mebendazole;   Drug: Vincristine;   Drug: Carboplatin;   Drug: Temozolomide;   Drug: Bevacizumab;   Drug: Irinotecan
    Sponsors:   Julie Krystal;   Janssen Pharmaceuticals
    Recruiting

  • Condition:   Multiple Sclerosis
    Interventions:   Drug: ACTHAR Gel (ACTH);   Drug: IV methylprednisolone (steroids)
    Sponsors:   University of Colorado, Denver;   Mallinckrodt;   University of Pennsylvania
    Recruiting

  • Conditions:   Amblyopia ex Strabismus;   Amblyopia ex Anisometropia
    Interventions:   Device: Dynamic Vessel Analyzer;   Other: Laser Doppler Velocimetry;   Device: 7-Tesla MRI;   Other: Pattern electroretinography;   Other: Fourier domain optical coherence tomography
    Sponsor:   Medical University of Vienna
    Recruiting

  • Conditions:   Adenoid Cystic Carcinoma;   Squamous Cell Carcinoma;   Sinonasal Carcinoma;   Sinonasal Undifferentiated Carcinoma;   Mucoepidermoid Carcinoma;   Schneiderian Carcinoma;   Myoepithelial Carcinoma;   Esthesioneuroblastoma;   Melanoma
    Interventions:   Radiation: Proton radiation therapy;   Radiation: Intensity-modulated radiotherapy
    Sponsors:   Massachusetts General Hospital;   National Institutes of Health (NIH);   National Cancer Institute (NCI)
    Recruiting

  • Conditions:   Vestibular Schwannoma;   Acoustic Neuroma
    Intervention:   Radiation: Fractionated proton radiation
    Sponsors:   Massachusetts General Hospital;   National Cancer Institute (NCI)
    Recruiting

  • Conditions:   Low Grade Glioma;   Recurrent Childhood Pilocytic Astrocytoma;   Recurrent Neurofibromatosis Type 1;   Recurrent Visual Pathway Glioma;   Refractory Neurofibromatosis Type 1;   Refractory Visual Pathway Glioma
    Interventions:   Other: Laboratory Biomarker Analysis;   Other: Pharmacological Study;   Drug: Selumetinib
    Sponsor:   National Cancer Institute (NCI)
    Recruiting

  • Conditions:   Neurofibromatosis Type 1;   Malignant Peripheral Nerve Sheath Tumor;   Plexiform Neurofibroma;   Optic Glioma;   Neurofibroma
    Intervention:  
    Sponsor:   National Cancer Institute (NCI)
    Recruiting